By Leroy Leo (Reuters) -Abbott Laboratories said on Thursday it is actively developing a test for monkeypox, as the disease spreads in various countries. The company will provide the test kits to partners of its Pandemic Defense Coalition, a network of scientific and public health partnerships aimed at identifying future pandemic threats, an Abbott spokesperson told Reuters. “As the situation evolves, we will take steps to address additional testing needs,” the spokesperson said. Abbott’s announcement comes on a day when the Centers for Diseases Control and Prevention (CDC) confirmed it has id…